GB/T 37272-2018
ActiveDetermination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in urine—Liquid chromatography-tandem mass spectrometry method
尿液中△9-四氢大麻酸的测定 液相色谱-串联质谱法
Application Summary AI generated
This standard specifies a liquid chromatography-tandem mass spectrometry method for detecting 11-nor-9-carboxy-delta-9-tetrahydrocannabinol, a primary metabolite of cannabis, in human urine. It is applied in forensic toxicology, workplace drug testing, and clinical diagnostics to confirm cannabis use or exposure. The method ensures accurate quantification for legal, occupational, or medical purposes.
Related Standards
GB/T 19546-2004
Medical and functional classificational of standing volleyball for disabled athletes
GB/T 19632-2005
Classification and codes for the service、equipments and articles of funeral and interment
GB/Z 40671-2021
Specification for operation technologies of traditional Chinese medicine—Surgery—Ligation therapy
GB/Z 40666-2021
Specification for operation technologies of traditional Chinese medicine一Dermatology一Vapor bath of Chinese materia medica
GB/Z 40668-2021
Specification for operation technologies of traditional Chinese medicine一Dermatology一Facial mask of Chinese materia medica
GB/Z 40667-2021
Specification for operation technologies of traditional Chinese medicine一Dermatology一Ion atomization of Chinese materia medica
GB/Z 40669-2021
Specification for operation technologies of traditional Chinese medicine—Surgery—Drawing therapy
GB/Z 40893.4-2021
Specification for operation technologies of traditional Chinese medicine—Pediatrics—Part 4:Tuina
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.